Aggrastat
Brand Name: Aggrastat
Active Ingredient:   tirofiban hydrochloride
Strength(s): 50mcg/ml and 250 mcg/ml
Dosage Form(s):   Injection
Company Name:    Merck & Co., Inc.
Availability:         Prescription only
*Date Approved by FDA:   May 14, 1998
  • You have very high blood pressure (greater than 180/110)
  • You are being treated with eptifibatide (Integrilin)
  • General Precautions:

    Aggrastat should be used with caution if you have a decreased blood platelet count or disease of the retina of the eye associated with bleeding.

    What should I tell my doctor or health care provider?

    Because certain medications can interact with Aggrastat, review all medications that you are taking with your doctor, including those that you take without a prescription. Tell your doctor if you are taking another drug that affects blood clotting such as Coumadin or warfain.

    What are some possible side effects of Aggrastat? (This is NOT a complete list of side effects reported with Aggrastat. Your health care provider can discuss with you a more complete list of side effects.)

    The most common complication reported during testing of the product was excessive bleeding. The increased bleeding is why some people (those who have had recent surgery, and other examples mentioned above) should not be given Aggrastat.

    Other possible side effects occurring in at least 3% or more of the people studied:

    • Pelvic pain
    • Slow heart rate
    • Tear in the coronary artery
    • Leg pain
    • Dizziness

    For more detailed information about Aggrastat, ask your health care provider.

    Aggrastat's Approved label  ../../graphics/Pdf.gif (146 bytes)

    Back to Entry Page

    Revised 7/25/00